Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breast Tumors from the NCCTG (Alliance) N9831 Trial
- Citation:
- J Natl Cancer Inst vol 109 (2)
- Year:
- 2016
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- These studies were supported in part by grants from the National Cancer Institute (CA129949), the Breast Cancer Research Foundation, and the 26.2 with Donna Foundation. Additional support for infrastructure was derived from the Mayo Clinic Comprehensive Cancer Center support grant CA15083 and the Mayo Foundation.
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 6
- Parents:
- 2374
- Children:
- None